Shionogi & Co. Ltd.

In News

Pfizer, GSK, Shionogi sponsor London run of musical about antimicrobial resistance - Fierce Pharma

Fierce Pharma - Dec 04, 2025

The Power to Create Medicines That Reach Patients—Passing SHIONOGI’s Baton of Innovation to the Next Generation - Shionogi Inc.

Shionogi Inc. - Oct 09, 2025

FDA Accepts Shionogi’s NDA for Ensitrelvir Oral Antiviral in COVID-19 Postexposure Prevention - Contagion Live

Contagion Live - Sep 02, 2025

Shionogi to buy Japan Tobacco's pharma units for over $1B - FirstWord Pharma

FirstWord Pharma - May 07, 2025

Shionogi Completes Acquisition of Japan Tobacco’s Pharmaceutical Business - TipRanks

TipRanks - Dec 01, 2025

BioVersys and Shionogi agree to develop ansamycin leads - Pharmaceutical Technology

Pharmaceutical Technology - Jul 03, 2025

Shionogi puts more than $600M on the table for Swiss biotech's antibiotic program - Fierce Biotech

Fierce Biotech - Jul 02, 2025

Can Shionogi’s Rally Continue After Key Drug Approval in 2025? - Yahoo Finance

Yahoo Finance - Sep 09, 2025

FDA Accepts Shionogi’s Ensitrelvir NDA as the First Oral Therapy for the Prevention of COVID-19 Following Exposure - Business Wire

Business Wire - Sep 02, 2025

Accelerating drug discovery with AI innovation - SAS: Data and AI Solutions

SAS: Data and AI Solutions - May 10, 2025

Yomiuri: Nobel Prize Winner, Shionogi Jointly Developing New Cancer Drug - MarketWatch

MarketWatch - Nov 13, 2025

BRIEF—Shionogi launches new form of Xofluza - The Pharma Letter

The Pharma Letter - Nov 12, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment